PB Fintech Limited, the parent company of Policybazaar, has announced a ₹539.40 crore investment in its wholly-owned subsidiary PB Healthcare Services Private Limited, as part of the first tranche of a seed funding round. The funding aligns with the company’s earlier shareholder approval of up to ₹696 crore, secured through a postal ballot on April 15, 2025.
The seed round totals ₹1,461.60 crore, with participation from PB Fintech and external investors. As a result of the fresh capital infusion and the creation of an Employee Stock Option Plan (ESOP) pool, PB Fintech’s stake in PB Healthcare will reduce from 100% to 32.14% on a fully diluted basis.
PB Healthcare, incorporated on January 1, 2025, operates in the healthcare and allied services sector. The investment aims to strengthen the subsidiary’s financial foundation and support future growth.
The funding was executed through the allotment of 5,39,40,000 Compulsory Convertible Preference Shares (CCPS) at ₹100 per share. The transaction is classified as a related-party deal but was conducted at fair market value, as determined by a registered valuer.
PB Fintech stated that the dilution is a strategic step to bring in long-term investors and build a robust team via ESOPs.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always consult a financial advisor before making investment decisions.
